Significant reduction in humoral Immunity among healthcare workers and nursing home residents 6 months AFTER COVID-19 BNT162b2 mRNA vaccination
DH Canaday, OA Oyebanji, D Keresztesy, M Payne… - MedRxiv, 2021 - medrxiv.org
High COVID-19 mortality among nursing home (NH) residents led to their prioritization for
SARS-CoV-2 vaccination; most NH residents received BNT162b2 mRNA vaccination under
the Emergency Use Authorization due to first to market and its availability. With NH residents'
poor initial vaccine response, the rise of NH breakthrough infections and outbreaks,
characterization of the durability of immunity to inform public health policy on the need for
boosting is needed. We report on humoral immunity from 2 weeks to 6-months post …
SARS-CoV-2 vaccination; most NH residents received BNT162b2 mRNA vaccination under
the Emergency Use Authorization due to first to market and its availability. With NH residents'
poor initial vaccine response, the rise of NH breakthrough infections and outbreaks,
characterization of the durability of immunity to inform public health policy on the need for
boosting is needed. We report on humoral immunity from 2 weeks to 6-months post …